Cargando…
Cisplatin radiosensitizes radioresistant human mesenchymal stem cells
Cisplatin-based chemo-radiotherapy is widely used to treat cancers with often severe therapy-associated late toxicities. While mesenchymal stem cells (MSCs) were shown to aid regeneration of cisplatin- or radiation-induced tissue lesions, the effect of the combined treatment on the stem cells remain...
Autores principales: | Rühle, Alexander, Perez, Ramon Lopez, Glowa, Christin, Weber, Klaus-Josef, Ho, Anthony D., Debus, Jürgen, Saffrich, Rainer, Huber, Peter E., Nicolay, Nils H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675674/ https://www.ncbi.nlm.nih.gov/pubmed/29152122 http://dx.doi.org/10.18632/oncotarget.21214 |
Ejemplares similares
-
Mesenchymal stem cells maintain their defining stem cell characteristics after treatment with cisplatin
por: Nicolay, Nils H., et al.
Publicado: (2016) -
Mesenchymal stem cells are sensitive to bleomycin treatment
por: Nicolay, Nils H., et al.
Publicado: (2016) -
Human mesenchymal stem cells lose their functional properties after paclitaxel treatment
por: Münz, Franziska, et al.
Publicado: (2018) -
Mesenchymal stem cells are resistant to carbon ion radiotherapy
por: Nicolay, Nils H., et al.
Publicado: (2014) -
Human mesenchymal stem cells are resistant to UV-B irradiation
por: Lopez Perez, Ramon, et al.
Publicado: (2019)